TriSalus Life Sciences, Inc.
TLSI · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $23 | $26 | $13 | $9 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $5 | $6 | $5 | $5 |
| Inventory | $3 | $4 | $4 | $4 |
| Other Curr. Assets | $2 | $2 | $2 | $3 |
| Total Curr. Assets | $33 | $38 | $25 | $21 |
| Property Plant & Equip (Net) | $3 | $3 | $3 | $3 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $3 | $3 | $4 | $3 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $36 | $41 | $29 | $24 |
| Liabilities | – | – | – | – |
| Payables | $0 | $2 | $3 | $2 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $11 | $7 | $9 | $8 |
| Total Curr. Liab. | $11 | $9 | $12 | $10 |
| LT Debt | $34 | $34 | $33 | $23 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $18 | $18 | $18 | $16 |
| Total NC Liab. | $52 | $51 | $51 | $40 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $1 | $1 | $2 |
| Total Liabilities | $63 | $61 | $63 | $50 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$321 | -$298 | -$290 | -$280 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $294 | $279 | $256 | $254 |
| Total Equity | -$27 | -$19 | -$34 | -$26 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $36 | $41 | $29 | $24 |
| Net Debt | $11 | $7 | $20 | $15 |